+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug & Gene Delivery Devices Market by Technology, Delivery Mode, Device Type, Molecule Type, Therapeutic Area, End User, Application - Global Forecast to 2030- Product Image
Drug & Gene Delivery Devices Market by Technology, Delivery Mode, Device Type, Molecule Type, Therapeutic Area, End User, Application - Global Forecast to 2030- Product Image
Sale

Drug & Gene Delivery Devices Market by Technology, Delivery Mode, Device Type, Molecule Type, Therapeutic Area, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336343
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The drug and gene delivery devices market is experiencing significant transformation, driven by technological advancement, regulatory shifts, and evolving patient needs. As new innovations reshape therapeutic administration and device integration, stakeholders are navigating a complex landscape that demands strategic clarity and data-backed decisions.

Market Snapshot: Drug & Gene Delivery Devices

The Drug & Gene Delivery Devices Market grew from USD 4.79 billion in 2024 to USD 5.32 billion in 2025. It is expected to continue growing at a CAGR of 10.75%, reaching USD 8.84 billion by 2030. This trajectory highlights rising demand for tailored delivery platforms, fueled by advances in biomaterials, device digitization, and patient-centric care models. Emerging therapies and expanded end-user adoption drive sustained investment and sectoral momentum.

Scope & Segmentation

  • Technology: Hydrogel based devices, liposomal systems, nanoparticle carriers, polymer based platforms.
  • Delivery Mode: Injectable formats (intramuscular, intravenous, subcutaneous), inhalation, oral, and transdermal devices (microneedles, patches).
  • Device Types: Auto injectors, infusion pumps, needle free injectors, pen injectors, syringes.
  • Molecule Types: Biologics (monoclonal antibodies, peptides, recombinant proteins), gene therapies (non-viral lipid-based and polymer-based, viral vectors such as adenoviral, lentiviral, retroviral), and small molecules.
  • Therapeutic Areas: Cardiovascular, diabetes, infectious diseases, oncology.
  • End Users: Clinics, hospitals, home healthcare, research laboratories.
  • Applications: Controlled release, smart delivery, sustained release, targeted delivery.
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), EMEA (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies: Becton Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Gerresheimer AG, Baxter International Inc., Nipro Corporation, Stevanato Group S.p.A., SHL Medical AG, Ypsomed Holding AG, Lonza Group AG.

Key Takeaways for Senior Decision-Makers

  • Advancements in biomaterials and miniaturization are leading to highly customizable, connected devices suitable for a broad range of therapeutic settings.
  • Integration of digital technology, including real-time monitoring and wireless connectivity, boosts treatment adherence and supports data-driven clinical decisions.
  • Chronic and rare diseases are prompting the evolution of versatile delivery solutions that maximize safety and patient comfort, with self-administration devices gaining traction in both home and clinical environments.
  • Biologics and gene therapies are accelerating the need for specialized device innovation, demanding tailored vectors and delivery approaches for new molecular entities.
  • Regional expansion is strongly influenced by reimbursement models, regulatory alignment, local manufacturing capabilities, and digital health initiatives.
  • Strategic industry partnerships—in biomaterials, digital solutions, and production—are enabling rapid response to market and policy developments.

Tariff Impact and Supply Chain Adaptation

The implementation of 2025 United States tariffs directly affects the supply chain for drug and gene delivery devices. Companies have responded by accelerating nearshoring of component production, diversifying supplier portfolios, and investing in alternative materials to counter rising input costs. These recalibrations safeguard operational continuity and allow manufacturers to meet quality and regulatory demands without significant interruption. Tariff-driven cost pressures, however, are prompting closer scrutiny of procurement models and healthcare delivery costs across regions.

Methodology & Data Sources

This report leverages a hybrid research approach. Extensive secondary research drew from peer-reviewed journals, regulatory documents, and industry publications, while targeted primary interviews with medical device executives, R&D specialists, and key opinion leaders validated findings and clarified market dynamics. Quantitative synthesis included triangulation of supply chain metrics, adoption rates, and patent trends. A rigorous peer review process ensured the reliability and robustness of the results.

Why This Report Matters

  • Enables strategic allocation of resources by clarifying growth drivers and risks within the evolving drug and gene delivery ecosystem.
  • Equips decision-makers with actionable insights for navigating supply chain shifts, technology adoption, and regulatory complexity across multiple geographies.
  • Supports informed partnership and investment strategies to accelerate competitive advantage in high-growth therapeutic segments.

Conclusion

As the drug and gene delivery devices market advances, industry leaders must adapt to technological evolution, regulatory shifts, and regional variations. This report provides the actionable intelligence needed to drive successful strategies in a continually changing environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug & Gene Delivery Devices Market, by Product Type
8.1. Introduction
8.2. Injectable Drug Delivery Devices
8.3. Nasal Drug Delivery Devices
8.4. Ocular Drug Delivery Devices
8.5. Oral Drug Delivery Devices
8.6. Pulmonary Drug Delivery Devices
8.7. Topical Drug Delivery Devices
8.8. Transdermal Drug Delivery Devices
9. Drug & Gene Delivery Devices Market, by Technology Type
9.1. Introduction
9.2. CRISPR Technology
9.3. Liposome Technology
9.4. Nanotechnology-Based Delivery
9.5. Non-Viral Gene Transfer
9.6. Polymer-Based Systems
9.7. Viral Gene Transfer
10. Drug & Gene Delivery Devices Market, by Application
10.1. Introduction
10.2. Cancer Therapeutics
10.3. Cardiovascular Diseases
10.4. Genetic Disorders
10.5. Infectious Diseases
10.6. Neurological Disorders
11. Drug & Gene Delivery Devices Market, by End User
11.1. Introduction
11.2. Biotechnology Firms
11.3. Hospitals
11.4. Pharmaceutical Companies
11.5. Research Institutes
11.6. Specialty Clinics
12. Drug & Gene Delivery Devices Market, by Drug Class
12.1. Introduction
12.2. Antisense Oligonucleotides
12.3. Biologics
12.4. Monoclonal Antibodies
12.5. Peptides
12.6. Proteins
12.7. RNA-Based Therapeutics
12.8. Small Molecule Drugs
13. Drug & Gene Delivery Devices Market, by Material Type
13.1. Introduction
13.2. Biodegradable Polymers
13.3. Biomaterials
13.4. Non-Biodegradable Polymers
14. Drug & Gene Delivery Devices Market, by Delivery Mechanism
14.1. Introduction
14.2. Controlled Release
14.3. Reverse Engineering
14.4. Sustained Release
14.5. Targeted Delivery
15. Drug & Gene Delivery Devices Market, by Base Material Type
15.1. Introduction
15.2. Natural
15.3. Semi-Synthetic
15.4. Synthetic
16. Drug & Gene Delivery Devices Market, by Device Type
16.1. Introduction
16.2. Integrated Inhaler Systems
16.3. Microneedles
16.4. Prefilled Syringes
16.5. Syringes & Needles
16.6. Wearable Injectors
17. Drug & Gene Delivery Devices Market, by Patient Demographics
17.1. Introduction
17.2. Adults
17.3. Geriatrics
17.4. Pediatrics
18. Drug & Gene Delivery Devices Market, by Regulatory Status
18.1. Introduction
18.2. Approved Devices
18.3. Research Phase
18.4. Under Clinical Trials
19. Americas Drug & Gene Delivery Devices Market
19.1. Introduction
19.2. Argentina
19.3. Brazil
19.4. Canada
19.5. Mexico
19.6. United States
20. Asia-Pacific Drug & Gene Delivery Devices Market
20.1. Introduction
20.2. Australia
20.3. China
20.4. India
20.5. Indonesia
20.6. Japan
20.7. Malaysia
20.8. Philippines
20.9. Singapore
20.10. South Korea
20.11. Taiwan
20.12. Thailand
20.13. Vietnam
21. Europe, Middle East & Africa Drug & Gene Delivery Devices Market
21.1. Introduction
21.2. Denmark
21.3. Egypt
21.4. Finland
21.5. France
21.6. Germany
21.7. Israel
21.8. Italy
21.9. Netherlands
21.10. Nigeria
21.11. Norway
21.12. Poland
21.13. Qatar
21.14. Russia
21.15. Saudi Arabia
21.16. South Africa
21.17. Spain
21.18. Sweden
21.19. Switzerland
21.20. Turkey
21.21. United Arab Emirates
21.22. United Kingdom
22. Competitive Landscape
22.1. Market Share Analysis, 2024
22.2. FPNV Positioning Matrix, 2024
22.3. Competitive Analysis
22.3.1. 3M Company
22.3.2. Antares Pharma, Inc.
22.3.3. B. Braun SE
22.3.4. Baxter International Inc.
22.3.5. Becton, Dickinson and Company
22.3.6. Eisai Co., Ltd.
22.3.7. Enable Injections, Inc.
22.3.8. Gerresheimer AG
22.3.9. Insulet Corporation
22.3.10. Johnson & Johnson Services Inc.
22.3.11. Koninklijke Philips N.V.
22.3.12. Merck KGaA
22.3.13. OraSure Technologies, Inc.
22.3.14. Oxford BioMedica PLC
22.3.15. Sanofi S.A.
23. ResearchAI
24. ResearchStatistics
25. ResearchContacts
26. ResearchArticles
27. Appendix
List of Figures
FIGURE 1. DRUG & GENE DELIVERY DEVICES MARKET MULTI-CURRENCY
FIGURE 2. DRUG & GENE DELIVERY DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. DRUG & GENE DELIVERY DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 24. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 26. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2024 VS 2030 (%)
FIGURE 28. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 32. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 36. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 37. DRUG & GENE DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 38. DRUG & GENE DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRUG & GENE DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INJECTABLE DRUG DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NASAL DRUG DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY OCULAR DRUG DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ORAL DRUG DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PULMONARY DRUG DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TOPICAL DRUG DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CRISPR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY LIPOSOME TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NANOTECHNOLOGY-BASED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON-VIRAL GENE TRANSFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY POLYMER-BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL GENE TRANSFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CANCER THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RNA-BASED THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REVERSE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SEMI-SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INTEGRATED INHALER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY SYRINGES & NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPROVED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY RESEARCH PHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY UNDER CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 102. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 104. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 107. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 108. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 109. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 110. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 111. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 112. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 115. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 119. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 120. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 121. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 122. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 123. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 159. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 161. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 164. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 165. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 166. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 167. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 168. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 169. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 170. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 172. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 175. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 176. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 177. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 178. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 179. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 180. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 183. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 192. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 194. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 197. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 198. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 199. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 200. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 201. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 202. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 203. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 205. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 208. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 209. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 210. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 219. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 221. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 222. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 223. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 224. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 227. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 230. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 231. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 232. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 233. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 234. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 235. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 243. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 244. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 245. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 246. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 247. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 249. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 252. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 253. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 254. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 255. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 256. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 257. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 258. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 260. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 263. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 264. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 265. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 266. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 267. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 268. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 276. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 278. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 279. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 292. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 294. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 297. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 298. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DELIVERY MECHANISM, 2018-2030 (USD MILLION)
TABLE 299. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY BASE MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 300. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 301. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 302. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGULATORY STATUS, 2018-2030 (USD MILLION)
TABLE 303. EGYPT DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. EGYPT DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 305. EGYPT DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. EGYPT DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Drug & Gene Delivery Devices market report include:
  • Becton Dickinson and Company
  • West Pharmaceutical Services, Inc.
  • Terumo Corporation
  • Gerresheimer AG
  • Baxter International Inc.
  • Nipro Corporation
  • Stevanato Group S.p.A.
  • SHL Medical AG
  • Ypsomed Holding AG
  • Lonza Group AG

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.32 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.84 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Drug and Gene Delivery Devices - Global Strategic Business Report - Product Image

Drug and Gene Delivery Devices - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Drug and Gene Delivery Devices Market Report 2025 - Product Image

Drug and Gene Delivery Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Gene Delivery Technologies Market by Delivery Vector Type, Therapeutic Application, Product, End User, Technology - Global Forecast to 2030 - Product Image

Gene Delivery Technologies Market by Delivery Vector Type, Therapeutic Application, Product, End User, Technology - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Gene Therapy Market, 6th Edition: Industry Trends and Global Forecasts to 2035 - Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method, Route of Administration, Geographical Region, Leading Market Players and Sales Forecast - Product Image

Gene Therapy Market, 6th Edition: Industry Trends and Global Forecasts to 2035 - Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method, Route of Administration, Geographical Region, Leading Market Players and Sales Forecast

  • Report
  • 972 Pages
  • Global
From

About the Drug and Gene Delivery Market

The Drug and Gene Delivery market within the context of Genomics is a rapidly growing field of research and development. It involves the use of various technologies to deliver drugs and genes to specific cells or tissues in the body. This can be done through a variety of methods, such as viral vectors, liposomes, nanoparticles, and other delivery systems. These technologies are used to treat a variety of diseases, including cancer, cardiovascular diseases, and neurological disorders. The Drug and Gene Delivery market is driven by the increasing demand for personalized medicine, as well as the need for more effective treatments for diseases. Additionally, advances in gene editing technologies have enabled the development of more precise and targeted therapies. Some of the major players in the Drug and Gene Delivery market include Novartis, Merck, Pfizer, Sanofi, and AstraZeneca. Other companies in the market include Amgen, GlaxoSmithKline, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.